High-dose interleukin-2 (HD IL-2) in the treatment of advanced melanoma: The University of Pittsburgh experience.
Diwakar Davar
No relevant relationships to disclose
Melissa Saul
No relevant relationships to disclose
Ahmad A. Tarhini
Consultant or Advisory Role - Prometheus
Research Funding - Prometheus
An Tran
No relevant relationships to disclose
Kerry Trent
No relevant relationships to disclose
Cindy Sander
No relevant relationships to disclose
John M. Kirkwood
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis; Vical
Research Funding - Prometheus
Hussein Abdul-Hassan Tawbi
No relevant relationships to disclose